226 related articles for article (PubMed ID: 26882490)
41. Efficacy and safety of oral mirodenafil in the treatment of erectile dysfunction in diabetic men in Korea: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Park HJ; Choi HK; Ahn TY; Park JK; Chung WS; Lee SW; Kim SW; Hyun JS; Park NC
J Sex Med; 2010 Aug; 7(8):2842-50. PubMed ID: 20626604
[TBL] [Abstract][Full Text] [Related]
42. Vardenafil: a review of its use in erectile dysfunction.
Keating GM; Scott LJ
Drugs; 2003; 63(23):2673-703. PubMed ID: 14636086
[TBL] [Abstract][Full Text] [Related]
43. Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomized, double-blind, pooled crossover study.
Rubio-Aurioles E; Porst H; Eardley I; Goldstein I
J Sex Med; 2006 Nov; 3(6):1037-1049. PubMed ID: 17100937
[TBL] [Abstract][Full Text] [Related]
44. Ten-year follow-up of sildenafil use in spinal cord-injured patients with erectile dysfunction.
Lombardi G; Macchiarella A; Cecconi F; Del Popolo G
J Sex Med; 2009 Dec; 6(12):3449-57. PubMed ID: 19686427
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.
Shabsigh R; Seftel AD; Kim ED; Ni X; Burns PR
J Sex Med; 2013 Mar; 10(3):844-56. PubMed ID: 23035781
[TBL] [Abstract][Full Text] [Related]
46. Safety and efficacy of sildenafil citrate in the treatment of Parkinson-emergent erectile dysfunction: a double-blind, placebo-controlled, randomized study.
Safarinejad MR; Taghva A; Shekarchi B; Safarinejad Sh
Int J Impot Res; 2010; 22(5):325-35. PubMed ID: 20861846
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of udenafil for erectile dysfunction: a meta-analysis of randomized controlled trials.
Ding H; Du W; Wang H; Zhang L; Wang Z; Du C; Tao Y
Urology; 2012 Jul; 80(1):134-9. PubMed ID: 22497982
[TBL] [Abstract][Full Text] [Related]
48. A meta-regression evaluating the effectiveness and prognostic factors of oral phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction.
Yuan JQ; Mao C; Yang ZY; Fu XH; Wong SY; Tang JL
Asian J Androl; 2016; 18(1):60-5. PubMed ID: 25966626
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Porst H; Giuliano F; Glina S; Ralph D; Casabé AR; Elion-Mboussa A; Shen W; Whitaker JS
Eur Urol; 2006 Aug; 50(2):351-9. PubMed ID: 16766116
[TBL] [Abstract][Full Text] [Related]
50. [Treatment of erectile dysfunction in patients with spinal cord injury].
Zhou HL
Zhonghua Nan Ke Xue; 2017 Feb; 23(2):99-102. PubMed ID: 29658245
[TBL] [Abstract][Full Text] [Related]
51. A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Therapeutic Confirmatory Study to Evaluate the Safety and Efficacy of Avanafil in Korean Patients with Erectile Dysfunction.
Park HJ; Kim SW; Kim JJ; Lee SW; Paick JS; Ahn TY; Park K; Park JK; Park NC
J Korean Med Sci; 2017 Jun; 32(6):1016-1023. PubMed ID: 28480661
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of medium and long-term tadalafil use in spinal cord patients with erectile dysfunction.
Lombardi G; Macchiarella A; Cecconi F; Del Popolo G
J Sex Med; 2009 Feb; 6(2):535-43. PubMed ID: 19138363
[TBL] [Abstract][Full Text] [Related]
53. The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction.
Sperling H; Debruyne F; Boermans A; Beneke M; Ulbrich E; Ewald S
J Sex Med; 2010 Apr; 7(4 Pt 1):1497-507. PubMed ID: 20233275
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of vardenafil for the treatment of erectile dysfunction in men with metabolic syndrome: results of a randomized, placebo-controlled trial.
Schneider T; Gleissner J; Merfort F; Hermanns M; Beneke M; Ulbrich E
J Sex Med; 2011 Oct; 8(10):2904-11. PubMed ID: 21771281
[TBL] [Abstract][Full Text] [Related]
55. Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): a randomized, double-blind, placebo-controlled trial in PDE5 inhibitor-naïve men with ED and their partners.
Edwards D; Hackett G; Collins O; Curram J
J Sex Med; 2006 Nov; 3(6):1028-1036. PubMed ID: 17100936
[TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of PDE5 inhibitors in the treatment of diabetes mellitus erectile dysfunction: Protocol for a systematic review.
Li X; Zhao Q; Wang J; Wang J; Dai H; Li H; Wang B
Medicine (Baltimore); 2018 Oct; 97(40):e12559. PubMed ID: 30290616
[TBL] [Abstract][Full Text] [Related]
57. Avanafil for erectile dysfunction.
Kyle JA; Brown DA; Hill JK
Ann Pharmacother; 2013 Oct; 47(10):1312-20. PubMed ID: 24259695
[TBL] [Abstract][Full Text] [Related]
58. The safety and efficacy of PDE5-inhibitors-vardenafil on treating diabetes mellitus erectile dysfunction: A protocol for systematic review and meta analysis.
He J; Li X; Dai HH; Wang JS; Li HS; Zhang XJ; Wang P; Zhang D; Zuo LY; Xie N; Li Y
Medicine (Baltimore); 2019 Dec; 98(51):e18361. PubMed ID: 31860994
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and satisfaction rates of oral PDE5is in the treatment of erectile dysfunction secondary to spinal cord injury: a review of literature.
Rizio N; Tran C; Sorenson M
J Spinal Cord Med; 2012 Jul; 35(4):219-28. PubMed ID: 22925748
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.
Broderick GA; Donatucci CF; Hatzichristou D; Torres LO; Valiquette L; Zhao Y; Loughney K; Sides GD; Ahuja S
J Sex Med; 2006 Jul; 3(4):668-675. PubMed ID: 16839323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
